Synapse - Works

Results (5225)

Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)

Meeting Abstract

Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
Blood (2018)

Fulltext@MSK | Save

The prognostic calculator EASIX predicts acute GVHD, non-relapse mortality and overall survival in adult patients undergoing reduced intensity conditioning allogeneic HCT

Meeting Abstract

Sanchez-Escamilla, M.; Hilden, P.; Maloy, M.; Fatmi, S. A.; Ponce, D.; Sauter, C. S.; Giralt, S.; Perales, M. A.
Blood (2018)

Fulltext@MSK | Save

Prognostic impact of insertion site in acute myeloid leukemia (AML) with FLT3 internal tandem duplication: Results from the ratify study (Alliance 10603)

Meeting Abstract

Rucker, F. G.; Du, L.; Blatte, T. J.; Benner, A.; Krzykalla, J.; Gathmann, I.; Larson, R. A.; Lo-Coco, F.; Amadori, S.; Prior, T. W.; more...
Blood (2018)

Fulltext@MSK | Save

Atezolizumab in combination with obinutuzumab and lenalidomide demonstrates favorable activity and manageable toxicity in patients with relapsed/refractory follicular lymphoma (FL): An interim analysis of a phase Ib/II trial

Meeting Abstract

Salles, G.; Ghosh, N.; Lossos, I. S.; Palomba, M. L.; Mehta, A.; Casasnovas, O.; Stevens, D.; Abajo, A.; Nielsen, T.; Chitra, S.; more...
Blood (2018)

Fulltext@MSK | Save

A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)

Meeting Abstract

Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
Blood (2018)

Fulltext@MSK | Save

Peripheral neuropathy is associated with an increased risk of fractures in individuals with monoclonal gammopathy of undetermined significance: A population-based study including 15,351 MGUS cases

Meeting Abstract

Rognvaldsson, S.; Thorsteinsdottir, S.; Turesson, I.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
Blood (2018)

Fulltext@MSK | Save

Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia

Meeting Abstract

Roboz, G. J.; Sugita, M.; Mosquera, J. M.; Wilkes, D. C.; Nataraj, S.; Jimenez-Flores, R. A.; Bareja, R.; Yan, L. B.; Eng, K. W.; Croyle, J. A.; more...
Blood (2018)

Fulltext@MSK | Save

Impact of CD34 cell dose infused on the duration of absolute neutropenia after high dose melphalan and autologous HCT for myeloma

Meeting Abstract

Bachier Rodriguez, L.; Shah, G. L.; Knezevic, A.; Devlin, S. M.; Maloy, M.; Koehne, G.; Chung, D. J.; Landau, H. J.; Giralt, S.
Blood (2018)

Fulltext@MSK | Save

Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant untreated AML: Results from a phase 1 dose escalation and expansion study

Meeting Abstract

Roboz, G. J.; DiNardo, C. D.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Donnellan, W. B.; Erba, H. P.; more...
Blood (2018)

Fulltext@MSK | Save

Survival for relapsed/refractory Hodgkin lymphoma patients with recurrent or persistent disease following autologous hematopoietic stem cell transplantation treated in the modern era

Meeting Abstract

Rajeeve, S.; Shah, G. L.; Moskowitz, C. H.; Moskowitz, A. J.
Blood (2018)

Fulltext@MSK | Save